Back to Search
Start Over
Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain.
- Source :
- Leukemia & Lymphoma; Aug2022, Vol. 63 Issue 8, p1993-1996, 4p
- Publication Year :
- 2022
-
Abstract
- This study shows that the clinical and biologic characteristics of adult patients with BL and BLL were similar to those of patients from the BL-IPI cohort. Consequently, the BL-IPI was validated in our series of patients with BL and BLL. Keywords: Burkitt lymphoma; prognosis; International Prognostic Index; validation EN Burkitt lymphoma prognosis International Prognostic Index validation 1993 1996 4 08/22/22 20220801 NES 220801 Chemoimmunotherapy including rituximab and high-dose or infusional chemotherapy constitute the standard treatment for patients with Burkitt's lymphoma (BL) or Burkitt's lymphoma and leukemia (BLL) [[1], [3]]. [Extracted from the article]
- Subjects :
- HIV infections
BURKITT'S lymphoma
Subjects
Details
- Language :
- English
- ISSN :
- 10428194
- Volume :
- 63
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- Leukemia & Lymphoma
- Publication Type :
- Academic Journal
- Accession number :
- 158597605
- Full Text :
- https://doi.org/10.1080/10428194.2022.2053531